Arianna Francesca Brasca

Maintained and updated media contact lists and databases for ease of access.

Tracked and reported on success of campaigns and public relations efforts.

Helped plan and execute private, company, and client events.

Drafted, edited and distributed press releases, media advisories and other public relations materials.

Account Assistant in the Healthcare Team. Strategic communications, public affairs, lobbying and media relations activities for Pharma Companies like Napisan, Prenatal, AstraZeneca, Suanfarma, Sofinnova, Bolton.

Journalistic activity about Russia, the Russia-Ukraine war,

and International Relations.

Journalistic activity about Russia, the Balkans, Europe and International Relations.

- International press office
- Updating mailing list
- Press review
- Monitoring press releases
- Supporting event-related content and guests

Journalistic activity about International Relations, Fashion Industry, Economics, Sustainability and Finance.

Journalistic activity and editing about regional issues.

Management of relations with the mass media: production of information and news, monitoring the mass media and relations with the mass media, press reviews, conception and realization of journalistic and informative products, publication of articles, and interviews.

Inside the prison houses of Opera and Bollate and the San Vittore prison house, the University of Milan offers workshops and teaching modules each year that encourage joint attendance by inmate and external students, thanks to the agreement signed with the Regional Superintendency of Prison Administration(PRAP).

The educational offerings of the Mario Negri Institute are mainly practical since they consist primarily of participation in experimental or clinical research projects. Students in the courses can be placed in a laboratory, use modern equipment, attend an up-to-date library, participate in seminars, and meet international scientific research personalities. In particular, the research process of an experimental anticancer drug was followed.

Molecular dynamics study on the p-53 protein: the study of mutations is a key starting point in cancer research.